Lori J. Goldstein, MD

Drs. Chugh and Baker's concisereview highlights diseaseentities we hear little of, andmay never see, but of which we mustbe cognizant. The article serves as avaluable reminder that not every breastmass that is palpated or detected byradiologic screening represents eithera carcinoma or benign entity such as afibroadenoma. Although rare, the nonepithelialmalignancies must beconsidered in a complete differentialdiagnosis.

Taxanes have been established in the treatment of metastatic breast cancer, and two presentations at the 20th Annual San Antonio Breast Cancer Symposium provide additional data to more clearly delineate the indications and potential use of these agents.